Docking of calcium-binding protein 1 of Entamoeba histolytica using FDA approved drugs

To find out an alternative potential inhibitor of Entamoeba histolytica calciumbinding protein 1 (EhCaBP1) through in silico studies. Methods: An attempt was made to find a new FDA approved, and cost effective alternative drug for amoebiasis. Sequence of the EhCaBP1 of Entamoeba histolytica was obtained through searching the UniProt database and protein BLAST was performed. The 3D structure of EhCaBP1 was retrieved from Research Collaboratory for Structural Bioinformatics and visualized using Discovery Studio Visualizer 3.1. A total of 100 drugs were selected and docked using Patchdock and the different sorts of interactions with the target protein were studied using GS viewer, Ligplot and Discovery Studio visualizer. Results: Among the 100 selected drugs, dolutegravir, cefazedone and ergotamine showed large number of interactions with the target protein.